MetGen Oy:電力:M&Aディール及び事業提携情報

◆英語タイトル:MetGen Oy - Power - Deals and Alliances Profile
◆商品コード:DATA904C3540
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:電力
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company offers metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosic chemical processes, deinked pulp applications, biochemical conversion process, starch conversion process, chemical pulp bleaching and extract control processes, among others. MetGen’s metzyme solutions revolutionize the production of bio-based chemicals by improving the productivity and economics of various processing procedures. The company serves pulp and paper, biofuel and biorefinery, and waste water treatment industries, among others. MetGen is headquartered in Kaarina, Finland.

MetGen Oy – Power – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Power eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MetGen Oy, Power, Deals By Year, 2012 to YTD 2018 5
MetGen Oy, Power Deals By Type, 2012 to YTD 2018 6
MetGen Oy, Power, Deals By Region, 2012 to YTD 2018 7
MetGen Oy, Power, Deals By Sector, 2012 to YTD 2018 8
MetGen Oy, Power, Deals Summary, 2012 to YTD 2018 9
MetGen Oy, Power, Deal Details 10
Venture Financing 10
MetGen Raises Capital In Series A Venture Financing 10
MetGen Raises Capital In Venture Financing 12
MetGen Raises US$3.5 Million In Venture Financing 13
MetGen Oy – Key Competitors 14
MetGen Oy – Key Employees 15
MetGen Oy – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
MetGen Oy, Power, Key Facts 2
MetGen Oy, Power, Deals Summary, 2012 to YTD 2018 2
MetGen Oy, Power, Deals By Year, 2012 to YTD 2018 5
MetGen Oy, Power Deals By Type, 2012 to YTD 2018 6
MetGen Oy, Power, Deals By Region, 2012 to YTD 2018 7
MetGen Oy, Deals By Sector, 2012 to YTD 2018 8
MetGen Oy, Power, Deals Summary, 2012 to YTD 2018 9
MetGen Raises Capital In Series A Venture Financing 10
MetGen Raises Capital In Venture Financing 12
MetGen Raises US$3.5 Million In Venture Financing 13
MetGen Oy, Key Competitors 14
MetGen Oy, Key Employees 15

List of Figures
MetGen Oy, Power, Deals by Type, 2012 to YTD 2018 2
MetGen Oy, Power, Deals By Year, 2012 to YTD 2018 2
MetGen Oy, Power, Deals By Region, 2012 to YTD 2018 2
MetGen Oy, Power, Deals By Sector, 2012 to YTD 2018 2
MetGen Oy, Power, Deals By Year, 2012 to YTD 2018 5
MetGen Oy, Power, Deals by Type, 2012 to YTD 2018 6
MetGen Oy, Power, Deals By Region, 2012 to YTD 2018 7
MetGen Oy, Power, Deals by Sector, 2012 to YTD 2018 8

★海外企業調査レポート[MetGen Oy:電力:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shanghai Shyndec Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Shyndec Pharmaceutical Co Ltd (Shanghai Shyndec) a subsidiary of China National Pharmaceutical Group Corp, is a pharmaceutical company which focuses on the production and sale of active pharmaceutical ingredients (API’s), oral preparations and finished drugs. Its product portfolio i …
  • ShawCor Ltd (SCL):企業の財務・戦略的SWOT分析
    ShawCor Ltd (SCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Capitol Health Ltd (CAJ)-医療機器分野:企業M&A・提携分析
    Summary Capitol Health Ltd (Capitol Health) is a medical device company that provides diagnostic imaging and related services. The company provides services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic re …
  • Poxel SA (POXEL):製薬・医療:M&Aディール及び事業提携情報
    Summary Poxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases. The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial dysfunction, for the treatment of type 2 diabetes; PXL065, a mitochondrial pyruvate ca …
  • Boditech Med Inc (206640):企業の製品パイプライン分析2018
    Summary Boditech Med Inc (Boditech) is a medical device company that manufactures and distributes in-vitro diagnostic analyzers and reagents. The company’s products include ichroma Reader, a portable fluorescence scanning instrument and AFIAS-6, a next-generation fluorescence processing and scanning …
  • M3 Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary M3 Biotechnology Inc (M3 Biotech) is a therapeutics company that concentrates on novel platform of pharmaceuticals that modifies growth-factor systems. The company provides therapies primarily for the treatment of neurodegenerative diseases. It develops small molecule modulators with a conce …
  • CGN Power Co Ltd (1816):企業の財務・戦略的SWOT分析
    CGN Power Co Ltd (1816) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Sekisui House, Ltd.:企業の戦略・SWOT・財務情報
    Sekisui House, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sekisui House, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ichibanya Co Ltd:企業の戦略・SWOT・財務分析
    Ichibanya Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Ichibanya Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Risco Energy Investments Pte Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Risco Energy Investments Pte Ltd (Risco Energy Investments) is an energy investment company that acquires, operates, runs, deals, manages, funds and commercialize oil and gas assets. The company undertakes hydrocarbon exploration, production, development, power generation and gas commerciali …
  • AvivaSA Emeklilik ve Hayat A.S.:企業の戦略・SWOT・財務分析
    AvivaSA Emeklilik ve Hayat A.S. - Strategy, SWOT and Corporate Finance Report Summary AvivaSA Emeklilik ve Hayat A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Astex Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • Corning Incorporated (GLW)-エネルギー分野:企業M&A・提携分析
    Summary Corning Incorporated (Corning) manufactures and sells ceramics, specialty glasses and related materials. The company’s product portfolio includes glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for tele …
  • Wenzel Downhole Tools Ltd:企業の戦略的SWOT分析
    Wenzel Downhole Tools Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Genor BioPharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Genor BioPharma Co Ltd (Genor) a subsidiary of Walvax Biotechnology Co Ltd is a bio-pharmaceutical company which develops and commercializes therapeutic monoclonal antibodies (mAbs), Fc-fusion proteins and recombinant therapeutic proteins. Its service offerings include process and assay deve …
  • Antibe Therapeutics Inc (ATE):企業の財務・戦略的SWOT分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …
  • NextEra Energy Inc (NEE):企業の財務・戦略的SWOT分析
    NextEra Energy Inc (NEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SignPath Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SignPath Pharma Inc (SignPath) is a developer of therapeutics based on its pure synthesized curcumin compounds. The company’s curcumin compounds acts as an anti-oxidant, anti-inflammatory and anti-cell recycling agent. It develops curcumin based products in different intravenous nanoparticle …
  • Ubisoft Entertainment SA (UBI):企業の財務・戦略的SWOT分析
    Ubisoft Entertainment SA (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Eregli Demir ve Celik Fabrikalari TAS:企業の戦略・SWOT・財務情報
    Eregli Demir ve Celik Fabrikalari TAS - Strategy, SWOT and Corporate Finance Report Summary Eregli Demir ve Celik Fabrikalari TAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆